MERMAID MEDICAL A/S
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
- Inspections (1)
Devices registered here (3)
- Catheter, Nephrostomy, General & Plastic SurgeryProduct code GBO (opens in a new tab) · Class I · General, Plastic Surgery · 21 CFR 878.4200
- Catheter, NephrostomyProduct code LJE (opens in a new tab) · Unclassified · Unknown
- Stents, Drains And Dilators For The Biliary DuctsProduct code FGE (opens in a new tab) · Class II · Gastroenterology, Urology · 21 CFR 876.5010
Recalls & enforcement
- Class IIOngoing2024-05-01Internal product testing failed bubble leak testing (ASTM F2096), which indicates the sterility barrier may not be fully intact.
- Class IITerminated2015-06-15Mermaid Medical A/S is recalling some of their M-Biopsy Coaxial Introducer Needles because of the potential for small plastic pieces to be present in the luer of the cannula.
FDA inspections (1)
- NAI2017-05-04No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “MERMAID MEDICAL A/S (FEI 3007146453) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3007146453-mermaid-medical-a-s/
Alerts for MERMAID MEDICAL A/S
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.